Archives of Medical Science, 2021 Introduction Gastric cancer remains the fourth leading cause of cancer-related death in Europe, while the proportion of adenocarcinomas of the esophagogastric junction has risen by more than one third over recent years.
Dimitrios Raptis +13 more
doaj +1 more source
Factors related to lymph node metastasis in Siewert type Ⅲ carcinoma of esophagogastric junction
Di-san junyi daxue xuebao, 2019 Objective To investigate the influencing factors for lymph node metastasis in Siewert type Ⅲ carcinoma of esophagogastric junction. Methods A total of 162 patients with Siewert type Ⅲ carcinoma of esophagogastric junction undergoing radical surgery in ...
SHEN Yonghua +3 more
doaj +1 more source
Surgical Case Reports, 2021 Background The abscopal effect is a rare phenomenon in which local irradiation causes tumor regression outside the irradiated area. There have been no reports of abscopal effect in patients with gastrointestinal melanoma with metastasis.
Takahisa Yamaguchi +10 more
doaj +1 more source
Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction [PDF]
, 2013 Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric ...
Arnold, Dirk +12 more
core +1 more source
Recurrence following anastomotic leakage after surgery for carcinoma of the distal esophagus and gastroesophageal junction. a systematic review [PDF]
, 2019 BACKGROUND: Esophageal cancer is the ninth most common cancer. The only potentially curative treatment is surgical resection, which unfortunately is still associated with major complications, the most important being anastomotic leakage, currently with ...
Antolino, Laura +8 more
core +1 more source
F-18-FDG and C-11-choline positron emission tomography in human esophago-gastric cancer : prediction of response to therapy [PDF]
, 2010 Peer reviewedPublisher ...
Hammonds, Solveig +8 more
core +1 more source
Esophageal and Esophagogastric Junction Cancers [PDF]
Journal of the National Comprehensive Cancer Network, 2011 Overview Upper gastrointestinal tract cancers originating in the esophagus, esophagogastric junction (EGJ), and stomach constitute a major health problem around the world. An estimated 37,640 new cases of and 25,070 deaths from upper gastrointestinal cancers occurred in the United States in 2010.1 A dramatic shift in the location of upper ...
Jaffer A, Ajani +28 more
openaire +2 more sources
Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma [PDF]
, 2013 This study aimed at determining the recommended dose of the mammalian target of rapamycin inhibitor everolimus in combination with mitomycin C (MMC) in patients with previously treated metastatic esophagogastric cancer.
Atmaca, Akin +5 more
core +1 more source
BMC Cancer, 2019 Background The prognosis of patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma is still dismal. There are no standard treatment strategies for these patients.
Xiaowen Liu +23 more
doaj +1 more source
Nowotwory, 2023 INTRODUCTION: The purpose of this study is to evaluate the effect of esophagogastric junction cancer (EGJC) staging on the risk of splenic hilar lymph node involvement. MATERIAL AND METHODS: 312 patients with EGJC after R0 surgery were analyzed; 118 (38%)
Tomasz Olesiński +4 more
doaj +1 more source